| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/27/1999 | US5928900 Amino acid sequences from streptococcus pneumoniae |
| 07/27/1999 | US5928899 Cell division regulators |
| 07/27/1999 | US5928895 IgA Fc binding protein |
| 07/27/1999 | US5928893 Monoclonal antibody specific for human 4-1BB and cell line producing same |
| 07/27/1999 | US5928879 Method of diagnosing human granulocytic Ehrlichiosis |
| 07/27/1999 | US5928865 Nucleic acids from region located 5' to cytotoxin associated protein locus; for diagnosis of gastrointestinal disorders associated with this bacteria; vaccines; antiulcer agents |
| 07/27/1999 | US5928861 Using specific antibodies against an epitope in the envelope protein gp46 for the detection of human t-cell leukemia virus in humans |
| 07/27/1999 | US5928650 Preventing bacterial meningitis caused by serogroup b using anon-polysaccharide |
| 07/27/1999 | US5928649 Administering interleukin or inducer concurrently with vaccine to swine or cattle |
| 07/27/1999 | US5928648 Recombinant herpesvirus of turkeys and uses thereof |
| 07/27/1999 | US5928647 Immunization with non-replicating protein antigens. the compositions of the invention comprise a particulate-protein complex |
| 07/27/1999 | US5928644 Amino acid-immunogen complexes used to generate an immune response against a pathogen |
| 07/27/1999 | US5928641 Having binding specificity for crossreactive epitopes shared by endoglin expressed on human vascular endothelial cells and endoglin expressed on murine vascular endothelial cells |
| 07/27/1999 | US5928639 Immunotherapy of cancer with allogeneic lymphocytes |
| 07/27/1999 | US5927230 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/27/1999 | CA2221843A1 Porcine reproductive and respiratory syndrome oral vaccine production in plants |
| 07/27/1999 | CA1340675C Vaccines and diagnostics derived from bovine diarrhea virus |
| 07/22/1999 | WO1999036552A1 Method for producing purified and optionally marked tsh receptor preparations, radioiodized tsh receptor preparations and the use of preparations of this type in diagnostics and therapy |
| 07/22/1999 | WO1999036544A2 Neisseria meningitidis antigens |
| 07/22/1999 | WO1999036540A1 Human chemokine and its use for detection and treatment of breast disease |
| 07/22/1999 | WO1999036521A1 A gene homologous to fox sperm acrosomal protein fsa-1 (cbcald05) |
| 07/22/1999 | WO1999036508A1 Histidine kinase |
| 07/22/1999 | WO1999036507A1 Vaccine compositions and methods of modulating immune responses |
| 07/22/1999 | WO1999036434A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus |
| 07/22/1999 | WO1999036433A2 Materials and methods for treating oncological disease |
| 07/22/1999 | WO1999036105A2 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE |
| 07/22/1999 | WO1999036094A2 Composition and method for treating metastatic tumors or cancer induced by cells expressing sv40 tumor antigen |
| 07/22/1999 | WO1999036093A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | WO1999036091A2 Method for inhibiting cd95-independent apoptosis in aids |
| 07/22/1999 | WO1999036090A1 Oral delivery of nucleic acid vaccines by particulate complexes |
| 07/22/1999 | WO1999036089A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |
| 07/22/1999 | WO1999036088A1 RECOMBINANT CtB-BASED VACCINES |
| 07/22/1999 | WO1999036087A1 Novel vaccine compositions for herpes simplex virus |
| 07/22/1999 | WO1999036086A1 Lipooligosaccharide-based vaccine for prevention of moraxella (branhamella) catarrhalis infections in mammals |
| 07/22/1999 | WO1999036085A1 Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes |
| 07/22/1999 | WO1999036084A1 Vaccine composition for herpes simplex virus and methods of using |
| 07/22/1999 | WO1999036056A1 Lipomatrix preparation |
| 07/22/1999 | WO1999028482A3 Single-chain recombinant complexes of hepatitis c virus ns3 protease and ns4a cofactor peptide |
| 07/22/1999 | WO1999028439A3 Erythrovirus and its applications |
| 07/22/1999 | WO1999027958A3 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 07/22/1999 | WO1999012971A3 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins |
| 07/22/1999 | WO1999005291A3 Aggrecan degrading metallo proteases |
| 07/22/1999 | WO1998059040A3 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 07/22/1999 | WO1998055495B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 07/22/1999 | WO1998044945A9 Non-infectious, protease defective hiv particles and nucleic acid molecules encoding therefor |
| 07/22/1999 | CA2318557A1 Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes |
| 07/22/1999 | CA2318556A1 Lipomatrix preparation |
| 07/22/1999 | CA2318525A1 Methods of using human receptor protein 4-1bb |
| 07/22/1999 | CA2318498A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |
| 07/22/1999 | CA2318493A1 Oral delivery of nucleic acid vaccines by particulate complexes |
| 07/22/1999 | CA2318439A1 Vaccine composition for herpes simplex virus and methods of using |
| 07/22/1999 | CA2318231A1 Use of radiolabeled monoclonal igm in therapy for cancer and autoimmune disease |
| 07/22/1999 | CA2317815A1 Neisseria meningitidis antigens |
| 07/22/1999 | CA2317810A1 Human chemokine and its use for detection and treatment of breast disease |
| 07/22/1999 | CA2315746A1 Lipooligosaccharide-based vaccine for prevention of moraxella (branhamella) catarrhalis infections in mammals |
| 07/21/1999 | EP0930316A1 Oral product for the prevention and treatment of infectious gastroenteritides in calves |
| 07/21/1999 | EP0929688A1 Sustained delivery device and methods of making and using the same |
| 07/21/1999 | EP0929679A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
| 07/21/1999 | EP0929678A2 Protein and peptide vaccines for inducing mucosal immunity |
| 07/21/1999 | EP0929677A2 Method for producing recombinants intended for use in a complete malaria antigene gp190/msp1 |
| 07/21/1999 | EP0929673A2 Tumor proteins |
| 07/21/1999 | EP0929672A1 Human gtp binding protein gamma-3 |
| 07/21/1999 | EP0929670A1 P-selectin ligand proteins |
| 07/21/1999 | EP0929579A1 Monoclonal antibodies against a human act and serine protease complex |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929575A1 Novel human growth factors |
| 07/21/1999 | EP0929568A2 Pharmaceutical compositions for the treatment of immune disorders |
| 07/21/1999 | EP0929318A2 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
| 07/21/1999 | EP0929317A2 Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof |
| 07/21/1999 | EP0929315A2 Cross-protective equine herpesvirus preparations and method of making and using the same |
| 07/21/1999 | EP0929310A1 Diagnostic and therapeutic methods related to regulating energy mobilization with ob protein and ob antibodies |
| 07/21/1999 | EP0929300A2 Cyanidin compositions and therapeutic and diagnostic uses therefor |
| 07/21/1999 | EP0929232A1 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
| 07/21/1999 | EP0374207B1 Drug for treating cancer, aids and viral diseases |
| 07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 07/21/1999 | CN1223689A Brain glycogen phosphorylase cancer antigen |
| 07/21/1999 | CN1223686A Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use |
| 07/21/1999 | CN1223685A Modulators of tissue regeneration |
| 07/21/1999 | CN1223590A Passively administered antibody that enhances feed conversion efficiency |
| 07/21/1999 | CN1223589A Feline vaccines containing chlamydia psittaci and method for making the same |
| 07/21/1999 | CN1223586A Recombinant vaccine for diseases caused by encapsulated organisms |
| 07/21/1999 | CN1223549A Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 07/21/1999 | CN1223546A Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 07/21/1999 | CN1223145A Carcinoembryonic antigen gene engineering antiboy CL-3-scFv |
| 07/20/1999 | US5925751 Human cytomegalovirus DNA sequences |
| 07/20/1999 | US5925741 A specific aspect of the present invention concerns bae which are revealed after virus-receptor interaction, e.g. hiv-cd4 interaction. |
| 07/20/1999 | US5925740 Antibodies to receptor for oncostatin M |
| 07/20/1999 | US5925734 The viral proteins also have superantigen-like activity, and inhibit ebv infection. |
| 07/20/1999 | US5925733 DNA polymerase of gamma herpes viruses associated with Kaposi's sarcoma and retroperitoneal fibromatosis |
| 07/20/1999 | US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology |
| 07/20/1999 | US5925568 It is also useful to be able to harvest haematopoietic cells prior to chemotherapy or radiotherapy, thus protecting them from the effects of this therapy; after therapy, the cells can be returned to the patient. |
| 07/20/1999 | US5925564 Expression vector systems and method of use |
| 07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
| 07/20/1999 | US5925555 Propagating virus with reverse transcriptase activity in brain cells |
| 07/20/1999 | US5925546 Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
| 07/20/1999 | US5925539 Human pelota homolog |
| 07/20/1999 | US5925536 Receptor-type phosphotyrosine phosphatase-β |
| 07/20/1999 | US5925521 Human serine carboxypeptidase |
| 07/20/1999 | US5925516 Medicaments for the treatment of papillomavirus diseases |
| 07/20/1999 | US5925512 Monoclonal antibody which specifically binds to mutant hepatitis b virus surface antigen ?a? determinant |